1ST-104

N/A

Report date: 2025/07/15 15:05:08

Base Information

Drug Name1ST-104
Drug Alias Name1ST-104
ClassificationBiologics
Mechanisms of ActionLeucine-rich repeat serine/threonine-protein kinase 2 modulatorsABL proto-oncogene 1 modulators
TargetsLeucine-rich repeat serine/threonine-protein kinase 2ABL proto-oncogene 1
Therapy Area/IndicationsAmyotrophic Lateral SclerosisParkinson DiseaseMultiple System Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies1st Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active Companies1st Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisParkinson DiseaseMultiple System Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A